Ra Capital Management, L.P. - Mar 29, 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Stock symbol
ANTX
Transactions as of
Mar 29, 2022
Transactions value $
$24,999,990
Form type
4
Date filed
3/31/2022, 04:31 PM
Previous filing
Mar 30, 2022
Next filing
May 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Conversion of derivative security +1.7M 1.7M Mar 29, 2022 See Footnotes F1, F2, F4
transaction ANTX Common Stock Purchase $23.3M +1.55M +91.24% $15.00 3.25M Mar 29, 2022 See Footnotes F2, F4
transaction ANTX Common Stock Conversion of derivative security +300K 300K Mar 29, 2022 See Footnotes F1, F3, F4
transaction ANTX Common Stock Purchase $1.73M +116K +38.54% $15.00 416K Mar 29, 2022 See Footnotes F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANTX Series B Preferred Stock Conversion of derivative security $0 -1.7M -100% $0.00* 0 Mar 29, 2022 Common Stock 1.7M See footnotes F1, F2, F4
transaction ANTX Series B Preferred Stock Conversion of derivative security $0 -300K -100% $0.00* 0 Mar 29, 2022 Common Stock 300K See footnotes F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 29, 2022, each share of Series B Preferred Stock (the "Preferred Stock") converted into Common Stock of the Issuer at a ratio of 1-for-1 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
F2 These securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
F3 These securities are held directly by RA Capital Nexus Fund II, L.P. (the "Nexus Fund II").
F4 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund II. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.